Arvinas Competitors and Similar CompaniesClear all
Arvinas's competitors and similar companies include Foghorn Therapeutics and NextCure.
 Arvinas Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases. |  Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. |  NextCure NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs. | |
Founding Date | Founding Date N/A | Founding Date 2016 | Founding Date 2015 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations New Haven, US HQ | Locations Cambridge, US HQ Cambridge, US | Locations Beltsville, US HQ |
Employees | Employees 13329% increase | Employees 1123% decrease | Employees N/A |
Valuation ($) | Valuation ($) 1.9 b | Valuation ($) 452 m | Valuation ($) 39.2 m |
Financial | |||
Revenue (est.) | Revenue (est.) $262.6m (FY, 2025) | Revenue (est.) $30.9m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($80.8m) (FY, 2025) | Net income ($74.4m) (FY, 2025) | Net income ($55.8m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 111.6m | Total funding raised $ 50m | Total funding raised $ 160m |
For sources of this data, please see the company profile
View Company Profiles
Foghorn Therapeutics
HQ
Cambridge, US
Employees
112↓ 3% decrease
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
View companyNextCure
HQ
Beltsville, US
NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.
View company